NCT05580705

Brief Summary

The study is aimed to determine the effects of sole-foot vibration therapy on pain intensity, static and dynamic balance, functional status and satisfaction to the intervention applied on patients with peripheral neuropathy due to type 2 diabetes mellitus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2022

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

October 11, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 14, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 22, 2023

Completed
Last Updated

April 6, 2023

Status Verified

April 1, 2023

Enrollment Period

5 months

First QC Date

October 11, 2022

Last Update Submit

April 5, 2023

Conditions

Keywords

Diabetes MellitusVibration TherapyDiabetic NeuropathyPainBalanceFunctional DisabilityPatient satisfactionRoutine Physical Therapy

Outcome Measures

Primary Outcomes (4)

  • Pain Intensity

    Pain Intensity will be measured by using Numeric Pain Rating Scale. Pain score range from 1-10, with 1 indicates least possible pain level and 10 is the worst pain level.

    Change in pain score will be measured at baseline, at the end of 1st week and 2nd week.

  • Dynamic and Static Balance

    Dynamic and static balance will be measured by using Berg Balance Scale. Its score range from 0 to 56, lower score represents more chances of losing balance and requirement of assistive measures.

    Change in Balance score will be measured at baseline, at the end of 1st week and 2nd week.

  • Level of Functional Disability

    Functional Disability will be measured by using Revised Neuropathy Disability Score. The total score is 10 with higher score indicates more severity of disease.

    Change in Functional Disability score will be measured at baseline, at the end of 1st week and 2nd week

  • Patient Satisfaction Level

    Patient Satisfaction Level will be measured by the Patient Satisfaction Questionnaire. Total score is 90. and higher score towards maximum value indicates higher level of satisfaction.

    Change in Patient Satisfaction Level will be measured at baseline, at the end of 1st week and 2nd week.

Study Arms (2)

ROUTINE PHYSICAL THERAPY GROUP

ACTIVE COMPARATOR

This group will receive routine physical therapy including strength training intervention. This protocol will be given for two weeks (6 sessions on alternate days, 3 sessions per week), outcomes will be measured at baseline, at the end of 1st week and 2nd week.

Other: Routine Physical Therapy

VIBRATION THERAPY

EXPERIMENTAL

This group will receive routine physical therapy and vibration therapy. This protocol will be given for two weeks (6 sessions on alternate days, 3 sessions per week), outcomes will be measured at baseline, at the end of 1st week and 2nd week.

Other: Vibration Therapy

Interventions

The Routine Physiotherapy treatment will include Transcutaneous Electrical Nerve Stimulation, Hot pack, Range of Motion (ROM) Exercises and Muscle Strengthening Exercises

ROUTINE PHYSICAL THERAPY GROUP

Vibration Therapy will include a vibration device of brand Manipol, model number RK-001. It has 360 degree off-centered axis with a frequency of 2500 times per minute. It will be applied on sole of the foot for about 15 mins.

VIBRATION THERAPY

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 40-75 years
  • Both male and female participants
  • On oral medicine for diabetes
  • HbA1C \<8.5%, and controlled blood sugar in the last three months
  • Patients with \< 6 years from diagnosis of diabetes
  • Diagnosed patient of peripheral neuropathy having type 2 diabetes by registered medical practitioner
  • Patient is able to stand on both feet.

You may not qualify if:

  • Systemic diseases such as advanced cardiovascular, renal, or hepatic diseases
  • Open wounds/ulcers on lower limb
  • Neurological illness that affects balance i.e. vertebral artery syndrome, Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, Stroke and cerebral ataxia
  • Musculoskeletal problems such as leg length discrepancy, ankle sprain and severe osteoarthritis of knee and hip joints
  • Patients who have performed vibration therapy exercises prior to intervention
  • Patient under any antihypertensive drugs and blood pressure more than 160/95 mm hg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Lahore

Lahore, Punjab Province, 54000, Pakistan

Location

Related Publications (1)

  • Bashir S, Jamil A, Ali S. Effects of vibration therapy with routine physical therapy on pain, balance, and functional disability in diabetic neuropathy patients: a randomised controlled trial. J Pak Med Assoc. 2025 Apr;75(4):534-539. doi: 10.47391/JPMA.20058.

MeSH Terms

Conditions

Diabetes MellitusDiabetic NeuropathiesPainPatient Satisfaction

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesDiabetes ComplicationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
It will be a single blinded study and the outcome assessor will be blinded to the treatment group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 11, 2022

First Posted

October 14, 2022

Study Start

September 22, 2022

Primary Completion

February 22, 2023

Study Completion

February 22, 2023

Last Updated

April 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will share

Immediately after publication

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning 9 months and ending on 36th month

Locations